Spotlight on Opioids

Gilbert LLP is a leader in the legal fight to stem the opioid epidemic.

Millions of Americans are addicted to prescription opioids, and tens of thousands die annually from opioid overdoses. Indeed, the number of people who take prescription opioids for non-medical purposes has far exceeded the number who use cocaine, heroin, and hallucinogens combined.

Gilbert LLP is a leader in the legal fight to abate the opioid epidemic throughout the nation and to establish effective, long-lasting solutions.  We approach this challenge with the same insight, innovation, and commitment we bring to every problem we confront—devising and implementing strategic, enterprising paths to the best outcomes possible.

The firm first attacked the epidemic by representing multiple states attorneys general and sovereign Indian tribes to investigate and litigate claims against opioid manufacturers, distributors, chain retailers and others seeking damages and other relief for their roles in causing and fueling the opioid crisis.  Gilbert brings to these cases and other pending opioid-related litigation its considerable experience and successful track record negotiating historic, complex multiparty settlements in mass-tort and other matters.

A short time later, we began to apply our insurance expertise to determine the extent to which insurance may be available to fund potential solutions to the opioid epidemic.  Most recently, following significant analysis of the insurance available to Purdue Pharma L.P., Gilbert LLP and other firms have filed the largest insurance coverage action filed to date concerning opioids (now pending in the United States Bankruptcy Court for the Southern District of New York).

Finally, the firm has attacked the crisis through strategic negotiation.  This work has included (1) settlements that led to bankruptcy filings and streamlined the resulting bankruptcy proceedings, (2) the negotiation of plans of reorganization in bankruptcy, and (3) representation of post-bankruptcy trusts.  In these respects, we represent the ad hoc committees of governmental plaintiffs in In re: Purdue Pharma LP and In re: Mallinckrodt PLC, and the Insys Victims Restitution Trust.